Terms: = Skin cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Clinical Outcome
40 results:
1. Influence of Post-radiation Ocular Surface Disorder on Ocular Surgery: A Case Report and Review of the Literature.
Gjukaj D; Morina I; Valmaggia C; Ammann D; Todorova MG
Klin Monbl Augenheilkd; 2024 Apr; 241(4):421-425. PubMed ID: 38653304
[TBL] [Abstract] [Full Text] [Related]
2. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment
Xu W; Lu J; Liu WR; Anwaier A; Wu Y; Tian X; Su JQ; Qu YY; Yang J; Zhang H; Ye D
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040418
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network.
Ugolini F; De Logu F; Iannone LF; Brutti F; Simi S; Maio V; de Giorgi V; Maria di Giacomo A; Miracco C; Federico F; Peris K; Palmieri G; Cossu A; Mandalà M; Massi D; Laurino M
Am J Pathol; 2023 Dec; 193(12):2099-2110. PubMed ID: 37734590
[TBL] [Abstract] [Full Text] [Related]
5. Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells.
Zhao Z; Ding Y; Tran LJ; Chai G; Lin L
Front Immunol; 2023; 14():1196892. PubMed ID: 37435067
[TBL] [Abstract] [Full Text] [Related]
6. A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
Gravis G; Marino P; Olive D; Penault-LLorca F; Delord JP; Simon C; Lamrani-Ghaouti A; Sabatier R; Ciccolini J; Boher JM
BMC Cancer; 2023 May; 23(1):393. PubMed ID: 37131154
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract] [Full Text] [Related]
8. Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China.
Du R; Wang X; Ma L; Larcher LM; Tang H; Zhou H; Chen C; Wang T
BMC Cancer; 2021 Feb; 21(1):206. PubMed ID: 33639888
[TBL] [Abstract] [Full Text] [Related]
9. Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients.
Huber V; Di Guardo L; Lalli L; Giardiello D; Cova A; Squarcina P; Frati P; Di Giacomo AM; Pilla L; Tazzari M; Camisaschi C; Arienti F; Castelli C; Rodolfo M; Beretta V; Di Nicola M; Maio M; Del Vecchio M; de Braud F; Mariani L; Rivoltini L
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589521
[TBL] [Abstract] [Full Text] [Related]
10. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract] [Full Text] [Related]
11. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF
Dummer R; Brase JC; Garrett J; Campbell CD; Gasal E; Squires M; Gusenleitner D; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Flaherty K; Larkin J; Robert C; Kefford R; Kirkwood JM; Hauschild A; Schadendorf D; Long GV
Lancet Oncol; 2020 Mar; 21(3):358-372. PubMed ID: 32007138
[TBL] [Abstract] [Full Text] [Related]
12. A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung cancer.
Dizier B; Callegaro A; Debois M; Dreno B; Hersey P; Gogas HJ; Kirkwood JM; Vansteenkiste JF; Sequist LV; Atanackovic D; Goeman J; van Houwelingen H; Salceda S; Wang F; Therasse P; Debruyne C; Spiessens B; Brichard VG; Louahed J; Ulloa-Montoya F
Clin Cancer Res; 2020 Apr; 26(7):1725-1735. PubMed ID: 31732522
[TBL] [Abstract] [Full Text] [Related]
13. The density and spatial tissue distribution of CD8
Massi D; Rulli E; Cossa M; Valeri B; Rodolfo M; Merelli B; De Logu F; Nassini R; Del Vecchio M; Di Guardo L; De Penni R; Guida M; Sileni VC; Di Giacomo AM; Tucci M; Occelli M; Portelli F; Vallacchi V; Consoli F; Quaglino P; Queirolo P; Baroni G; Carnevale-Schianca F; Cattaneo L; Minisini A; Palmieri G; Rivoltini L; Mandalà M;
J Immunother Cancer; 2019 Nov; 7(1):308. PubMed ID: 31730502
[TBL] [Abstract] [Full Text] [Related]
14. Pigmentation of conjunctival melanoma recurrences and outcome.
Brouwer NJ; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1783-1788. PubMed ID: 31098751
[TBL] [Abstract] [Full Text] [Related]
15. Diagnosis and treatment of hindfoot osteoid osteoma: A therapeutic method for each case.
Mellado-Romero MA; Vilá-Rico J; Gallego-Herrero C; Sánchez-Herraéz S; Casas-Ramos P; Santos-Sánchez JA; Ramos-Pascua LR
Rev Esp Cir Ortop Traumatol (Engl Ed); 2019; 63(3):165-172. PubMed ID: 30922598
[TBL] [Abstract] [Full Text] [Related]
16. IRF4 rs12203592 functional variant and melanoma survival.
Potrony M; Rebollo-Morell A; Giménez-Xavier P; Zimmer L; Puig-Butille JA; Tell-Marti G; Sucker A; Badenas C; Carrera C; Malvehy J; Schadendorf D; Puig S
Int J Cancer; 2017 Apr; 140(8):1845-1849. PubMed ID: 28103633
[TBL] [Abstract] [Full Text] [Related]
17. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
Roszik J; Haydu LE; Hess KR; Oba J; Joon AY; Siroy AE; Karpinets TV; Stingo FC; Baladandayuthapani V; Tetzlaff MT; Wargo JA; Chen K; Forget MA; Haymaker CL; Chen JQ; Meric-Bernstam F; Eterovic AK; Shaw KR; Mills GB; Gershenwald JE; Radvanyi LG; Hwu P; Futreal PA; Gibbons DL; Lazar AJ; Bernatchez C; Davies MA; Woodman SE
BMC Med; 2016 Oct; 14(1):168. PubMed ID: 27776519
[TBL] [Abstract] [Full Text] [Related]
18. Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells.
Zhou J; Cheng Y; Tang L; Martinka M; Kalia S
Oncotarget; 2017 Mar; 8(12):18712-18725. PubMed ID: 27213583
[TBL] [Abstract] [Full Text] [Related]
19. Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival.
Potrony M; Carreras E; Aranda F; Zimmer L; Puig-Butille JA; Tell-Martí G; Armiger N; Sucker A; Giménez-Xavier P; Martínez-Florensa M; Carrera C; Malvehy J; Schadendorf D; Puig S; Lozano F
Int J Cancer; 2016 Sep; 139(6):1297-302. PubMed ID: 27169428
[TBL] [Abstract] [Full Text] [Related]
20. TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines.
Pasini L; Re A; Tebaldi T; Ricci G; Boi S; Adami V; Barbareschi M; Quattrone A
BMC Cancer; 2015 Oct; 15():777. PubMed ID: 26496938
[TBL] [Abstract] [Full Text] [Related]
[Next]
